Asaf Danziger
2021
In 2021, Asaf Danziger earned a total compensation of $1.2M as Chief Executive Officer at NovoCure, a 87% decrease compared to previous year.
Compensation breakdown
| Salary | $876,086 |
|---|---|
| Other | $303,197 |
| Total | $1,179,283 |
Danziger received $876.1K in salary, accounting for 74% of the total pay in 2021.
Danziger also received $303.2K in other compensation.
Rankings
In 2021, Asaf Danziger's compensation ranked 8,185th out of 12,405 executives tracked by ExecPay. In other words, Danziger earned more than 34.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,185 out of 12,405 | 34th |
Division Manufacturing | 3,618 out of 5,494 | 34th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 463 out of 798 | 42nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 290 out of 519 | 44th |
Industry Surgical and Medical Instruments and Apparatus | 186 out of 324 | 43rd |
Source: SEC filing on April 25, 2022.
Danziger's colleagues
We found four more compensation records of executives who worked with Asaf Danziger at NovoCure in 2021.